The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2020

Filed:

Sep. 30, 2011
Applicants:

Mehmet Z. Sengun, Canton, MA (US);

William Parrish, Hudson, MA (US);

Gregory R. Whittaker, Stoneham, MA (US);

Douglas A. Fifolt, Wrentham, MA (US);

Brooks J. Story, Franklin, MA (US);

Inventors:

Mehmet Z. Sengun, Canton, MA (US);

William Parrish, Hudson, MA (US);

Gregory R. Whittaker, Stoneham, MA (US);

Douglas A. Fifolt, Wrentham, MA (US);

Brooks J. Story, Franklin, MA (US);

Assignee:

DEPUY SYNTHES PRODUCTS, INC, Raynham, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/14 (2015.01); A61K 35/17 (2015.01); A61K 38/18 (2006.01); A61L 27/22 (2006.01); A61L 27/38 (2006.01); A61K 35/19 (2015.01); A61L 27/54 (2006.01); A61L 15/32 (2006.01); A61K 38/36 (2006.01); A61K 38/55 (2006.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 35/14 (2013.01); A61K 35/19 (2013.01); A61K 38/18 (2013.01); A61K 38/1808 (2013.01); A61K 38/1825 (2013.01); A61K 38/1841 (2013.01); A61K 38/1866 (2013.01); A61K 38/1875 (2013.01); A61K 38/363 (2013.01); A61K 38/55 (2013.01); A61L 15/32 (2013.01); A61L 27/225 (2013.01); A61L 27/38 (2013.01); A61L 27/54 (2013.01); A61L 2300/414 (2013.01);
Abstract

Compositions and methods are provided for tissue constructs that promote wound healing. The composition comprises a dimensionally stable fibrin construct for local administration to a wound site or region. In one embodiment, the fibrin construct is a wound healing composition, including components that promote wound healing, such as platelets, growth factors, white blood cells and fibrin clots. In another embodiment, the tissue treatment composition includes (i) aggregated fibrin, (ii) blood cells, and (iii) optionally, growth factors and/or other proteins.


Find Patent Forward Citations

Loading…